Phase 3 study for people with Chronic Rhinosinusitis

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 15 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor GlaxoSmithKline
Registry number NCT07782957
Started 3 September 2026 Today 16 October 2026 Estimated completion 6 March 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
GSK Investigational Site Murdoch WA Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 218

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* 18 years of age and older

* Male or eligible female participants

* Physician-diagnosed CRSwNP for greater than or equals to (\>=) 12 months before screening.

* Have had at least one of the following at Visit 1:

* Any documented history of Nasal surgery for the removal of NP (or contraindications/intolerance to Nasal surgery)

* Have used at least 3 consecutive days of Systemic corticosteroid (SCS) or 1 intramuscular depot injectable dose (or contraindications/intolerance to SCS) in the previous 12 months (but not in the past 3 months before screening) for the treatment of NP.

* Endoscopic bilateral NP score consistent with severe CRSwNP assessed by the investigator.

* Symptoms of Chronic rhinosinusitis (CRS)

* Presence of symptoms of CRS for at least 12 weeks prior to Visit 1 such as rhinorrhea and/or reduction or loss of smell and

* Moderate to severe nasal congestion/blockade/obstruction at Visit 1 based on clinical assessment by the investigator.

* Participants must have an elevated SNOT-22 score at screening.

* Participants must be on daily treatment with intranasal corticosteroids (INCS) (including intranasal liquid steroid wash/douching) for at least the 8 weeks prior to screening.

Exclusion Criteria:

* As a result of medical interview, physical examination, or screening investigation the physician responsible considers the participant unfit for the study.

* Have the following conditions:- Cystic fibrosis, Antrochoanal polyps, Nasal cavity tumor (malignant or benign), Fungal rhinosinusitis, Rhinitis medicamentosa, Hyper-eosinophilic syndrome (HES) Eosinophilic granulomatosis with polyangiitis (EGPA) or Churg-Strauss Syndrome or eosinophilic esophagitis, Helminth parasitic infection in the past 6 months unless treated and have responded to therapy.

* Female who are pregnant

* Known substance or alcohol abuse

* Current smokers (including e-cigarettes) or ex-smokers of 6 months or less

* Other significant medical conditions (eg immunogenicity, Human immunodeficiency virus \[HIV\], viral hepatitis, tuberculosis \[TB\], cardiac and liver disease) that could impact participants' safety or study outcomes.

* Where nasal surgery is contraindicated

* Nasal surgery in the past 6 months

* Asthma exacerbation in the past 4 weeks.

Dates on the record

Started 3 September 2026
Estimated completion 6 March 2029
Registry last updated 9 October 2026
Checked by Voxsanity 15 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 9 October 2026.
  • This page last checked by Voxsanity: 15 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.